CELENTANO, ALDO
 Distribuzione geografica
Continente #
NA - Nord America 1.361
EU - Europa 756
AS - Asia 653
SA - Sud America 28
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.802
Nazione #
US - Stati Uniti d'America 1.344
SG - Singapore 384
UA - Ucraina 347
HK - Hong Kong 162
CN - Cina 96
FI - Finlandia 79
DE - Germania 73
IT - Italia 69
RU - Federazione Russa 69
GB - Regno Unito 47
NL - Olanda 46
BR - Brasile 25
CA - Canada 16
IE - Irlanda 14
SE - Svezia 8
FR - Francia 2
IQ - Iraq 2
MA - Marocco 2
TH - Thailandia 2
TR - Turchia 2
AR - Argentina 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
IN - India 1
JP - Giappone 1
MX - Messico 1
OM - Oman 1
PK - Pakistan 1
VE - Venezuela 1
Totale 2.802
Città #
Jacksonville 347
Santa Clara 299
Singapore 251
Hong Kong 162
Chandler 86
Princeton 78
Boston 73
Millbury 54
Amsterdam 44
Wilmington 41
Nanjing 32
Norwalk 20
Boardman 17
Ottawa 15
Shenyang 13
Nanchang 12
Houston 10
Hebei 8
Jiaxing 7
Orange 7
Changsha 5
Kunming 5
Naples 5
Seattle 5
Tianjin 5
Napoli 4
Ann Arbor 3
Beijing 3
Des Moines 3
São Paulo 3
Belo Horizonte 2
Bédoin 2
Eindhoven 2
Hangzhou 2
Moscow 2
Munich 2
Americana 1
Arapiraca 1
Bologna 1
Boscotrecase 1
Campo Grande 1
Cheadle 1
Contagem 1
Dallas 1
Dearborn 1
Dhaka 1
Engenheiro Caldas 1
Falls Church 1
Fremont 1
Fucecchio 1
Giresun 1
Governador Valadares 1
Grand Rapids 1
Indiana 1
Jaguariaíva 1
Jaguarão 1
Kollam 1
La Carlota 1
Loria 1
Madrid 1
Manaus 1
Mexico City 1
Miranda 1
Mosul 1
Muscat 1
Nova Iguaçu 1
Nuremberg 1
Patrocínio Paulista 1
Perm 1
Porto Alegre 1
Portovelo 1
Rabat 1
Rawalpindi 1
Redmond 1
Rio das Ostras 1
San Francisco 1
Santa Luzia 1
Santana do Livramento 1
Sapucaia do Sul 1
Shanghai 1
Springfield 1
Sumé 1
São Fidélis 1
Uberaba 1
Volta Redonda 1
Walnut 1
Wenzhou 1
Yalova 1
Zhengzhou 1
Totale 1.682
Nome #
Metabolic risk factors and left ventricular hypertrophy. 52
Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism 50
EARLY ABNORMALITIES OF CARDIAC FUNCTION IN NON-INSULIN DEPENDENT DIABETES MELLITUS AND IMPAIRED GLUCOSE TOLERANCE 49
ANTI-HYPERTENSIVE EFFECT OF MANIDIPINE: 24 HOUR MONITORING EVALUATION AND DOPPLER ECHOCARDIOGRAPHIC REMARKS 49
ASSOCIATION OF LEFT VENTRICULAR HYPERTROPHY WITH METABOLIC RISK FACTORS: THE YPER-GEN STUDY 47
A FAST AND ACCURATE METHOD FOR GENOTYPING THE ANGIOTENSIN-CONVERTING ENZYME (ACE) I/D POLYMORPHISM. 46
BLOOD PRESSURE AND CARDIAC MORPHOLOGY IN YOUNG SONS OF HYPERTENSIVE SUBJECTS. 45
AMBULATORY BLOOD PRESSURE MONITORING IN OFFSPRING OF HYPERTENSIVE PATIENTS: RALATION TO LEFT VENTRICULAR STRUCTURE AND FUNCTION 45
CLINICAL STUDY OF THE EFFICACY AND TOLERABILITY OF COMBINED DELAPRIL-INDAPAMIDE IN HYPERTENSION 45
CARDIOVASCULAR RISK FACTORS, ANGIOTENSIN-CONVERTING ENZYNE GENE I/D POLYMORPHISM AND LEFT VENTRICULAR MASS IN SYSTEMIC HYPERTENSION 45
EMERGENZE IPERTENSIVE, CARDIOPATIA ISCHEMICA (ANGINA PECTORIS E INFARTO MIOCARDICO ACUTO), SCOMPENSO CARDIACO, ARITMIE 45
Early abnormalities of the cardiac function in non-insulin dependent diabetes and impaired glucose tolerance. 45
CARDIOVASCULAR ABNORMALITIES IN NEVER TREATED HYPERTENSIVES ACCORDING TO NON-DIPPER STATUS. 43
CITIZENS AND FAMILY DOCTORS FACING AWARENESS AND MANAGEMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS: RESULTS FROM THE GLOBAL CARDIOVASCULA RISK REDUCTION PROJECT (HELP YOUR HEART STAY YOUNG STUDY) 43
EFFICACIA ANTIARITMICA E TOLLERABILITA’ DELLA MEXILETINA “SLOW RELASE” IN CONFRONTO CON IDROCHINIDINA RITARDO 42
ATENOLOL AND ATRIAL FIBRILLATION:EVALUATION BY SYSTOLIC TIME INTERVALS. 41
ARRHYTHMIAS, HYPERTENSION AND THE ELDERLY:HOLTER EVALUATION 41
ASSENZA DI ASSOCIAZIONE TRA L'ALLELE D DEL GENE DELL'ACE E PRESSIONE ARTERIOSA ESSENZIALE LIEVE-MODERATA. 41
RELATION OF LEFT VENTRICULAR DIASTOLIC PROPERTIES TO SYSTOLIC FUNCTION IN ARTERIAL HYPERTENSION 41
COMPARATIVE EVALUATION OF THE ANTHYPERTENSIVE EFFICACY OF ONCE-DAILY SUSTAINED-RELASE ISRADIPINE AND LACIDIPINE USING 24-HOUR AMBULATORY BLOOD-PRESSURE MONITORING 41
CLINIC-DAY TIME BLOOD PRESSURE DIFFERENCE AND CARDIOVASCULAR DAMAGE 40
PREVENZIONE CARDIOVASCOLARE: AIUTA IL TUO CUORE A RIMANERE GIOVANE 39
SODIUM-HYDROGEN EXCHANGE AND CARDIAC HYPERTROPHY IN PATIENTS WITH PRIMARY HYPERTENSION 38
TECNICHE DI ANESTESIA AMBULATORIALE NELLA INTERRUZIONE VOLONTARIA DI GRAVIDANZA 38
HYPERCOAGULABILITY AND ATHERO-THROMBOSIS: CLINICAL SUGGESTIONS AND PERSPECTIVES 38
Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. 38
morte improvvisa 38
SLOW-RELASE ISRADIPINE IN MILD TO MODERATE HYPERTENSION: HEMODINAMIC AND ANTIHYPERTENSIVE EFFECTS 37
LIVELLI SIERICI DI GLUCOSIO, INSULINA, CORTISOLO E ORMONE SOMATOTROPO NELLE FASI PRE-OPERATORIA E POST-OPERATORIA 37
EARLY CHANGES OF THE ARTERIAL CAROTID WALL IN UNCOMPLICATED PRIMARY HYPERTENSIVE PATIENTS: STUDY BY ULTRASOUND HIGH-RESOLUTION B-MODE IMAGING. 37
INFLUENCE OF CARDIOVASCULAR RISK FACTORS ON RELATION BETWEEN ACE-GENE POLYMORPHISM AND BLOOD PRESSURE IN ARTERIAL HYPERTENSION 37
GENDER DIFFERENCES IN LEFT VENTRICULAR CHAMBER AND MIDWALL SYSTOLIC FUNCTIONAL IN NORMOTENSIVE AND HYPERTENSIVE ADULTS 37
INTERSTUDY REPRODUCIBILITY OF PARAMETERS OF LEFT VENTRICULAR DIASTOLIC FUNCTION: A DOPPLER ECHOCARDIOGRAPHY STUDY 36
INAPPROPRIATE LEFT VENTRICULAR MASS AND ANGIOTENSIN CONVERTING ENZYME GENE POLYMORPHISM 36
CARDIAC ABNORMALITIES IN YOUNG WOMEN WITH ANOREXIA NERVOSA 36
RELATION BETWEEN SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS EARLY AFTER MYOCARDIAL INFARCTION 36
LIPOPROTEINS AND ARRHYTHMIAS: PROGNOSTIC VALUE 36
KETANSERIN ALONE AND IN COMBINATION WITH ENALAPRIL IN THE TREATMENT OF ESSENTIAL HYPERTENSION: ASSESSMENT OF THE HEMODYNAMIC EFFECTS 35
LA NICARDIPINA NEL TRATTAMENTO DELL'IPERTENSIONE ARTERIOSA: VALUTAZIONE ECOCARDIOGRAFICA 35
EFFECTS OF NICARDIPINE ON CHRONIC STABLE EFFORT ANGINA: A NON INVASIVE ASSESSMENT 35
VALUTAZIONE EMODINAMICA DELL'EFFICACIA DEL CANREONATO DI POTASSIO 35
LEFT VENTRICULAR GEOMETRY AND ARTERIAL FUNCTION IN HYPERCHOLESTEROLEMIA 35
PULMONARY VENOUS FLOW AND MITRAL INFLOW VELOCITY PATTERN IN UNCOMPLICATED OBESITY: EVIDENCE FOR LATE DIASTOLIC DYSFUNCTION 35
pulse pressure:letter 35
Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. 35
REDUCTION OF LEFT VENTRICULAR MASS BY SHORT-TERM ANTHYPERTENSIVE TREATMENT WITH ISRADIPINE: A DOUBLE BLIND COMPARISON WITH ENALAPRIL 34
HYPERTENSION AND ARRHYTHMIAS: EFFECTS OF SLOW-RELEASE NICARDIPINE VS CHLORTHALIDONE. A DOUBLE-BLIND CROSSOVER STUDY 34
SERUM CHOLESTEOL AFFECTS BLOOD PRESSURE REGULATION 34
RELATION OF THE HEART RATE TO LEFT VENTRICULAR DIMENSION IN NORMOTENSIVE, NORMAL-WEIGHT CHILDREN, ADOLESCENTS AND ADULTS 34
LEFT VENTRICULAR HYPERTROPHY, COMPLIANCE AND VENTRICULAR FILLING 34
PEAK EXERCISE OXYGEN UPTAKE AND LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTION AND ARTERIAL MECHANICS IN HEALTHY YOUNG MEN. 34
EFFICACIA ANTIARITMICA E TOLLERABILITA DELLA MEXILETINA SLOW-RELASE IN CONFRONTO CON IDROCHINIDINA RETARD 34
ISOLATED EPISODES OF ATRIAL FIBRILLATION AND ACUPUNCTURE 34
RELATION OF FIBRINOGEN TO MORTALITY INDEPENDENT OF PRE-CLINICAL CARDIOVASCULAR DISEASE. THE STRONG HEART STUDY 34
IMPACT OF MYOCARDIAL DIASTOLIC DYSFUNCTION ON CORONARY FLOW RESERVE IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY 34
Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring 34
"PROGETTO SINTESI": UN SOFTWARE NELLA PREVENZIONE CARDIOVASCOLARE 33
VALUTAZIONE HOLTER NELL'INSUFFICIENZA CORONARICA: INCIDENZA DEI FATTORI DI RISCHIO SULLE ARITMIE E SULLA ISCHEMIA MIOCARDICA 33
LEFT VENTRICULAR MYOCARDIAL IMPAIRMENT IN SUBCLINICAL HYPOTHYROIDISM ASSESSED BY A NEW ULTRASOUND TOOL: PULSED TISSUE DOPPLER 33
RELATION OF HEMODYNAMICS AND RISK FACTORS TO VENTRICULAR- VASCULAR INTERACTIONS IN THE ELDERLY: THE CARDIOVASCULAR HEALTH STUDYOF CONCENTRIC GEOMETRY 33
RELATION OF INSULIN RESISTANCE TO MARKERS OF PRECLINICAL CARDIOVASCULAR DISEASE: THE STRONG HEART STUDY. 33
LEFT VENTRICULAR CHAMBER AND WALL MECHNAICS IN THE PRESENCE OF CONCENTRIC GEOMETRY 33
NICARDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION: ASSESSMENT OF ITS ACTION ON BLOOD PRESSURE AND VENTRICULAR FUNCTION 32
HYPERTROPHY AT ECG AND IST REGRESSION DURING TREATMENT SURVEY (HEART SURVEY). RATIONALE, DESIGN AND BASELINE CHARACTERISTICS OF PATIENTS 32
PARENTAL LEFT VENTRICULAR HYPERTROPHY PREDICTS DOPPLER DERIVED DIASTOLIC FILLING IN YOUNG OFFSPRING OF HYPERTENSIVE SUBJECTS 32
PRAZOSINA E ATENOLOLO NEL TRATTAMENTO DELL'IPERTENSIONE ARTERIOSA: CONFRONTO E ASSOCIAZIONE 32
MILD ARTERIAL HYPERTENSION AND IMPAIRED GLUCOSE TOLERANCE: SHORT EFFECTS OF MANIDIPINE HYDROCHLORIDE 31
IL RUOLO DEL MODULO DI INTERROGAZIONE DELLA BANCA DATI "SINTESI" TRA RICERCA SCIENTIFICA E PRATICA MEDICA 31
MANAGEMENT OF PATIENT WITH LEFT VENTRICULAR HYPERTROPHY 31
EFFECTS ON CASUAL AND 24 H AMBULATORY BLOOD PRESSURE OF SLOW-RELASE NICARDIPINE AND CHLORTHALIDONE IN ARTERIAL ESSENTIAL HYPERTENSION. DOUBLE-BLIND, CROSSOVER STUDY 30
RELATION OF LEFT VENTRICULAR CHAMBER AND MIDWALL FUNCTION TO AGE IN NORMAL CHILDREN, ADOLESCENTS AND ADULTS 30
Pulmonary venous flow and mitral inflow velocity pattern in uncomplicated obesity: evidence for late diastolic dysfunction. 30
Cardiac abnormalities in young women with anorexia nervosa. 30
TERAPIA FARMACOLOGICA NEL POST INFARTO: VALUTAZIONE HOLTER 29
Increased troponin I predicts in-hospital occurrence of hemodynamic instability in patients with sub-massive or non-massive pulmonary embolism independent to clinical, echocardiographic and laboratory information. 26
KETANSERIN IN ELDERLY: COMPARISON AND COMBINATION WITH ENALAPRIL 25
Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study 25
Ketanserin alone and in combination with enalapril in the treatment of essential hypertension: assessment of the haemodynamic effects 24
Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril 24
Totale 2.876
Categoria #
all - tutte 12.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 0 0 0 0 0 1 8 76
2020/2021579 3 69 69 70 69 88 69 1 72 0 69 0
2021/2022268 0 0 0 2 0 8 3 17 17 6 84 131
2022/2023277 78 5 1 4 40 30 0 23 37 46 10 3
2023/2024148 8 25 6 1 5 1 4 1 0 0 56 41
2024/20251.010 116 259 0 2 78 204 233 75 43 0 0 0
Totale 2.876